Additional file 5 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

  • Chiara Naro (Creator)
  • Ambra Antonioni (Creator)
  • Vanessa Medici (Creator)
  • Cinzia Caggiano (Creator)
  • Ariane Jolly (Creator)
  • Pierre de la Grange (Creator)
  • Pamela Bielli (Creator)
  • Maria Paola Paronetto (Creator)
  • Claudio Sette (Creator)

Dataset

Description

Additional file 5: Supplementary Table S10. List of annotated splicing events regulated by Pladienolide B, Indisulam and THZ531 in 22Rv1 cells compared to control (fold change >=2, p-value
Dati resi disponibili2024
Editorefigshare

Cita questo